Science|Business
Policy Analysis: Investment, Life Sciences
Horizon 2020 Special Coverage
The Innovation Connection - The 2014 Science|Business Summit
The 2014 Science|Business Summit will bring together leaders from research, industry and policy to debate current future trends needed to unleash Europe's technological potential.
Berlin - 07 October 2014
So you want to start a company?
A workshop on forming a university spin-out company. Jointly organised by Science|Business and ASTP Proton as part of the ESOF conference.
Copenhagen - 25 June 2014
ACES Selection Committee
The Academic Enterprise Awards (ACES) Selection Committee meets to short list the finalists of the 2014 awards.
Copenhagen - 23 June 2014
Small companies, big ideas: How intellectual property helps SME's grow
In early 2014, Science|Business interviewed some of Europe’s hottest tech start-ups about their experience with IP management. We analysed the results on 4 March at the European Parliament.
Published:
UCL spin out sold to Amgen in $1 billion deal

University College London cancer vaccines spin-out BioVex has been bought by US biotech company Amgen in deal worth up to $1 billion.


BioVex, a cancer vaccines specialist spun out of University College London (UCL) is being acquired by US biotechnology giant Amgen in an all-cash deal worth up to $1 billion. Amgen is paying $425 million upfront, with a further $575 million to come on reaching some clinical and regulatory milestones.

The acquisition is a welcome return for the venture capital (VC) investors who have supported the company through six private rounds of investment, since it was formed in...

This page requires a Science|Business Network Membership

This page is available to Science|Business Network Members only. If you are already a member then please log in (above).

Note if you are only registered to receive our Bulletin, or have previously purchased an item from our store, this does not give you access to the full benefits of the site. Join Now and plug into the Science|Business Network to get full access to all our news, events and business opportunities.

Science|Business is the first independent media company that brings together researchers, investors and policy makers in the European innovation community. It does so with a top-quality team and unique network of Europe's leading scientific institutions, corporations, policy makers and IP and VC specialists.

Be where innovation begins – become a member. Click here to learn more.



Related subjects: Cancer

Advertisement